QLT Settles Visudyne Royalty Spat For $20M

Law360, New York (November 25, 2009, 3:31 PM EST) -- Pharmaceutical firm QLT Inc. has reached a $20 million settlement with Massachusetts General Hospital, putting to rest a royalty dispute related to sales of an eye treatment.

Canada-based QLT said Wednesday that under the terms of the deal, the $20 million payment to MGH will be taken as payment in full for all past and future royalty obligations under a licensing agreement related to the eye treatment Visudyne, and MGH’s pending lawsuit against QLT will be dismissed.

"We are pleased to put this matter behind us...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.